Werewolf Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of therapeutics engineered to stimulate the body’s immune system for the treatment of cancer. The firm offers Predator Technology which focuses on immune targeting and activation. The company was founded by Daniel J. Hicklin, Patrick A. Baeuerle, and Luke B. Evnin on October 19, 2017 and is headquartered in Watertown, MA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
46
Frequently Asked Questions
What is Market Cap of Werewolf Therapeutics Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Werewolf Therapeutics Inc market cap is $65.39M.
What is the 52-week high for Werewolf Therapeutics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Werewolf Therapeutics Inc 52 week high is $4.18 as of September 16, 2025.
What is the 52-week low for Werewolf Therapeutics Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Werewolf Therapeutics Inc 52 week low is $0.595 as of September 16, 2025.
What is Werewolf Therapeutics Inc stock price today?
Werewolf Therapeutics Inc stock price today is $1.38.
What was Werewolf Therapeutics Inc stock price yesterday?
Werewolf Therapeutics Inc stock price yesterday was $1.43.
What is the PE ratio of Werewolf Therapeutics Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Werewolf Therapeutics Inc’s P/E ratio is -0.87.
What is the Price-to-Book ratio of Werewolf Therapeutics Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Werewolf Therapeutics Inc P/B ratio is 1.5635.
What is the 50-day moving average of Werewolf Therapeutics Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Werewolf Therapeutics Inc 50-day moving average is $1.29.
How many employess does Werewolf Therapeutics Inc has?